Skip to main content

E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Maruta S, Sakai H, Kanda S, Hayashi T, Kanetake H, Miyata Y. E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer. APMIS 2009; 117: 791–6.

E1AF is associated with malignant aggressiveness via regulation of matrix metalloproteinases (MMPs), which play pivotal roles in invasion through the degradation of extracellular matrix of tissues surrounding tumors. However, the clinical significance of E1AF and MMPs in patients with prostate cancer is not fully understood. We reviewed 50 tissue samples from patients with T2-3N0M0 prostate cancer who had undergone radical operation. Expression levels of E1AF, MMP-1, -3, -7, -9 and -14 were determined semiquantitatively by immunohistochemistry. The mean ± SD percentage of E1AF-stained cancer cells was 8.56 ± 5.22, and it was significantly higher (p < 0.001) than the E1AF-immunostaining index of normal cells (1.17 ± 0.61). E1AF immunostaining index in pT3 (12.74 ± 4.80) was significantly higher (p < 0.001) than that in pT2 (5.78 ± 3.31). Although E1AF expression correlated with that of MMP-7 and MMP-9 (r = 0.47, p < 0.001 and r = 0.41, p = 0.004, respectively), multivariate analysis showed that E1AF correlated with only MMP-7 expression (OR = 5.81, 95% CI = 1.27–26.59, p = 0.023). Our results demonstrated that increased expression of E1AF is involved in tumor aggression of prostate cancer. This finding may be influenced by regulation of MMP-7. We speculate that E1AF is a possible target in treatment and prevention of tumor growth in prostate cancer.

Keywords: E1AF; Prostate cancer; growth; matrix metalloproteinases

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1600-0463.2009.02534.x

Affiliations: 1: Department of Urology, Nagasaki University School of Medicine, Sakamoto, Nagasaki 2: National Hospital Organization Nagasaki Hospital, Sakuragi-cho, Nagasaki 3: Department of Pathology, Nagasaki University Hospital, Sakamoto, Nagasaki, Japan

Publication date: 2009-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more